The National Institute of Health and Clinical Excellence (NICE) has published new guidance for the month of March 2013. This month there is one clinical guideline that impacts upon primary care.
The Hyperphosphataemia in chronic kidney disease guideline offers evidence-based advice on the care of adults, children and young people with stage 4 or 5 chronic kidney disease (CKD) who have, or are at risk of, hyperphosphataemia. It contains recommendations for the dietary management of hyperphosphataemia and the use of phosphate binders.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.
|« SMC Update - March 2013||Drug Safety Update - March 2013 »|